Nutanix Inc SEC Filings

BlackRock, Inc. reported beneficial ownership of 27,876,671 shares of Nutanix, Inc. Class A stock, representing 10.4% of the class as of the reporting event date 09/30/2025. The filing states BlackRock has sole voting power over 26,345,955 shares and sole dispositive power over 27,876,671 shares, with no shared voting or dispositive power disclosed. The Schedule 13G/A indicates these holdings are held in the ordinary course of business and were not acquired to influence control of Nutanix. The filing references Exhibit 24 (Power of Attorney) and Exhibit 99 (Item 7) for subsidiary identification details.

Nutanix, Inc. reported a proposed sale of 144,707 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $11,059,204.05. The filing lists the approximate sale date as 10/02/2025 on NASDAQ. The shares to be sold were acquired from multiple compensation events: performance shares granted on 03/15/2024 (14,346 shares) and 09/15/2024 (89,394 shares), restricted stock grants on 03/15/2024 (25,159 shares) and 09/15/2025 (2,318 shares), an employee purchase on 03/20/2024 (741 shares) paid in cash, and additional performance shares on 09/15/2025 (12,749 shares). The filing states no securities were sold by the person in the prior three months and includes the standard representation about no undisclosed material adverse information.

Nutanix, Inc. reported a proposed sale of 3,500 shares of its Common stock on a Form 144 filed as a live submission. The shares were acquired as Restricted Stock from the Issuer on 12/08/2024 and the filing lists an approximate sale date of 10/02/2025. The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services and the aggregate market value of the planned sale is reported as $267,690.85. The filing also discloses 268,800,007 shares outstanding and states there were no securities sold in the past three months by the reporting person.

Nutanix, Inc. (NTNX) Form 4: Chief Legal Officer Brian Martin reported sales and remaining holdings on 09/30/2025. He sold 10,241 shares of Class A common stock in multiple transactions at a weighted average price of $76.5288 per share under a Rule 10b5-1 trading plan adopted July 1, 2025. Following the reported sale, the filing shows 5,166 shares beneficially owned. The report also notes acquisition of 229 shares under the company Employee Stock Purchase Plan on 09/22/2025. The Form 4 was signed by an attorney-in-fact, Raymond Hum.

Form 144 filed for Nutanix, Inc. (NTNX) reporting a proposed sale of 10,241 common shares through Morgan Stanley Smith Barney LLC on 09/30/2025 on NASDAQ, with an aggregate market value of $783,731.44. The filing shows the shares were acquired on 09/15/2025 from the issuer as restricted stock (5,561 shares) and performance shares (4,680 shares). No securities were reported sold in the past three months, and the filer certifies they are not aware of undisclosed material adverse information.

Nutanix reported continued subscription-led growth and updated capital allocation authority. Subscription revenue classified as ratable and upfront rose materially: ratable subscription components were $905.8M, $1,029.0M and $1,138.4M for fiscal 2023–2025, while upfront subscription software license revenue was $825.0M, $987.8M and $1,272.4M for the same years, showing strong year‑over‑year increases.

The Board expanded the share repurchase program: an initial $350.0M authorization from August 2023 was increased by $350.0M in August 2025, with no expiration and repurchases to occur at management discretion. Unbilled accounts receivable were $41.1M and $83.5M as of July 31, 2024 and 2025, respectively. Non‑portable software revenue declined from $37.4M (2023) to $10.8M (2025). The filing discloses low effective interest rates on convertible notes (0.52% for 2027 Notes; 0.93% for 2029 Notes) and $500.0M principal outstanding of the 2027 Notes after a stated transaction.

Robert G. Lavender, a director of Nutanix, Inc. (NTNX), was granted restricted stock units (RSUs) that cover 843 shares of Class A common stock. The RSUs were issued on 09/17/2025 at no cash price and remain unvested. They vest in full on the earlier of (i) the day before the next annual meeting of shareholders after the grant date or (ii) the one-year anniversary of the grant, provided the reporting person continues service through the applicable vesting date. The Form 4 was filed on 09/19/2025 by an attorney-in-fact.

Robert G. Lavender, identified as a director of Nutanix, Inc. (NTNX), submitted an initial Form 3 reporting his relationship to the issuer and providing a business address in San Jose, CA. The filing states no securities are beneficially owned by the reporting person. The form was filed individually and includes a power of attorney signature on behalf of Mr. Lavender.